MedPageToday -- Treatment with the factor Xa inhibitor fondaparinux (Arixtra) was effective in preventing complications in patients with acute superficial-vein thrombosis of the legs, an international double-blind study found.
MedPageToday -- Treatment with the factor Xa inhibitor fondaparinux (Arixtra) was effective in preventing complications in patients with acute superficial-vein thrombosis of the legs, an international double-blind study found.
